— Know what they know.
Not Investment Advice

INSP NYSE

Inspire Medical Systems, Inc.
1W: -0.7% 1M: +11.0% 3M: +41.5% YTD: -24.2% 1Y: -3.3% 3Y: -63.7% 5Y: -71.7%
$69.97
-0.81 (-1.14%)
 
Weekly Expected Move ±8.1%
$59 $64 $70 $76 $81
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 70 · $2.0B mcap · 27M float · 3.27% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
66.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 19.7%  ·  5Y Avg: 17.6%
Cost Advantage
68
Intangibles
72
Switching Cost
62
Network Effect
77
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. INSP has a Narrow competitive edge (66.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 19.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$54
Low
$68
Avg Target
$85
High
Based on 9 analysts since Aug 3, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 16Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$63.91
Analysts11
Consensus Change History
DateFieldFromTo
2026-02-13 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-01 RBC Capital — $60 $75 +15 +8.1% $69.36
2026-09-11 Stifel Nicolaus Jonathan Block $75 $80 +5 +17.4% $68.12
2026-08-04 Evercore ISI — $40 $54 +14 -14.0% $62.78
2026-08-04 Truist Financial — $54 $62 +8 +18.7% $52.22
2026-08-04 RBC Capital Shagun Singh $45 $60 +15 -4.8% $63.00
2026-08-04 Stifel Nicolaus — $70 $75 +5 +43.6% $52.22
2026-08-04 Oppenheimer — $175 $85 -90 +62.8% $52.22
2026-08-04 Piper Sandler — $55 $60 +5 +14.9% $52.22
2026-08-04 Robert W. Baird — $50 $59 +9 +13.0% $52.22
2026-07-28 UBS Patrick Wood $67 $39 -28 -23.4% $50.93
2026-07-16 Truist Financial — $50 $54 +4 +3.3% $52.28
2026-06-23 Evercore ISI Daniel Markowitz $55 $40 -15 -3.3% $41.35
2026-05-22 Summit Redstone Partners — Initiated $39 — -12.8% $44.74
2026-05-05 Truist Financial Richard Newitter $64 $50 -14 +8.8% $45.95
2026-05-05 RBC Capital — $56 $45 -11 +0.0% $44.98
2026-05-05 Evercore ISI — $125 $55 -70 +20.7% $45.56
2026-05-05 Robert W. Baird David Rescott $74 $50 -24 -8.8% $54.84
2026-05-05 Piper Sandler Adam Maeder $85 $55 -30 +0.3% $54.84
2026-04-15 Truist Financial — $96 $64 -32 +11.1% $57.59
2026-04-14 RBC Capital Shagun Singh $68 $56 -12 +2.0% $54.92
2026-04-13 Mizuho Securities — $85 $70 -15 +31.0% $53.42
2026-04-10 Stifel Nicolaus — $85 $70 -15 +29.7% $53.96
2026-03-05 Stifel Nicolaus Jonathan Block $95 $85 -10 +36.5% $62.29
2026-02-18 Morgan Stanley — $130 $60 -70 -3.1% $61.95
2026-02-13 UBS — $96 $67 -29 +6.2% $63.06
2026-02-12 RBC Capital — $90 $68 -22 +9.6% $62.04
2026-02-12 Stifel Nicolaus — $110 $95 -15 +58.8% $59.83
2026-02-12 Piper Sandler — $165 $85 -80 +24.6% $68.21
2026-02-12 Mizuho Securities — $130 $85 -45 +24.6% $68.21
2026-02-12 Wells Fargo — $145 $70 -75 +2.6% $68.21
2026-02-12 Robert W. Baird — $180 $74 -106 +8.5% $68.21
2026-01-26 RBC Capital — $175 $90 -85 +10.7% $81.33
2026-01-22 UBS — $91 $96 +5 +18.8% $80.80
2026-01-22 Truist Financial Richard Newitter $120 $96 -24 +18.8% $80.81
2026-01-22 Evercore ISI Daniel Markowitz $150 $125 -25 +54.7% $80.81
2026-01-14 Wells Fargo — $90 $145 +55 +56.8% $92.46
2026-01-08 Truist Financial Richard Newitter $165 $120 -45 +21.2% $99.03
2025-12-23 UBS Danielle Antalffy $89 $91 +2 -7.1% $97.93
2025-12-17 RBC Capital — $125 $175 +50 +51.5% $115.51
2025-12-17 Mizuho Securities — $110 $130 +20 +12.5% $115.51
2025-12-08 Oppenheimer — Initiated $175 — +27.9% $136.81
2025-12-08 Piper Sandler — $135 $165 +30 +20.6% $136.81
2025-12-04 Robert W. Baird — $252 $180 -72 +33.6% $134.75
2025-12-02 Morgan Stanley — $200 $130 -70 +2.9% $126.34
2025-11-25 Truist Financial — $128 $165 +37 +26.5% $130.39
2025-11-25 Wolfe Research — Initiated $180 — +53.5% $117.29
2025-11-24 Truist Financial — $90 $128 +38 +10.5% $115.86
2025-11-24 Stifel Nicolaus Jonathan Block $100 $110 +10 +22.4% $89.87
2025-11-04 RBC Capital — $150 $125 -25 +47.5% $84.77
2025-11-04 Piper Sandler GAAP EPS $150 $135 -15 +59.1% $84.87

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
2
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. INSP receives an overall rating of A. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (2/5).
Rating Change History
DateFromTo
2026-09-18 A+ A
2026-08-28 A A+
2026-08-17 A+ A
2026-07-01 A A+
2026-06-02 A+ A
2026-05-11 A A+
2026-04-22 A- A
2026-04-01 A A-
2026-02-17 B+ A
2026-02-12 B- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 73 Grade A+
Profitability
50
Balance Sheet
92
Earnings Quality
81
Growth
61
Value
77
Momentum
85
Safety
100
Cash Flow
76
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. INSP scores highest in Safety (100/100) and lowest in Profitability (50/100). An overall grade of A+ places INSP among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
9.38
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✗
Beneish M-Score
-2.64
Unlikely Manipulator
Ohlson O-Score
-13.33
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.0/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.16x
Accruals: -2.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. INSP scores 9.38, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. INSP scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. INSP's score of -2.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. INSP's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. INSP receives an estimated rating of AAA (score: 96.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). INSP's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.01x
PEG
0.09x
P/S
2.25x
P/B
2.44x
P/FCF
11.03x
P/OCF
8.22x
EV/EBITDA
12.03x
EV/Revenue
1.11x
EV/EBIT
15.17x
EV/FCF
8.54x
Earnings Yield
10.46%
FCF Yield
9.07%
Shareholder Yield
7.75%
Graham Number
$54.73
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.0x earnings, INSP trades at a reasonable valuation. An earnings yield of 10.5% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $54.73 per share, 28% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.946
NI / EBT
×
Interest Burden
1.053
EBT / EBIT
×
EBIT Margin
0.073
EBIT / Rev
×
Asset Turnover
1.040
Rev / Assets
×
Equity Multiplier
1.150
Assets / Equity
=
ROE
18.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. INSP's ROE of 18.0% is driven by Asset Turnover (1.040), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.95 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$179.65
Price/Value
0.25x
Margin of Safety
75.17%
Premium
-75.17%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with INSP's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $179.65, INSP appears undervalued with a 75% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 15.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$69.98
Median 1Y
$58.86
5th Pctile
$20.15
95th Pctile
$172.28
Ann. Volatility
61.5%
Analyst Target
$63.91
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Timothy P. Herbert
President and Chief Executive Officer
$750,572 $5,999,655 $7,711,784
Carlton W. Weatherby
Chief Strategy Officer
$506,250 $1,899,947 $2,835,087
Randall A. Ban
Chief Commercial Officer
$490,794 $1,899,947 $2,729,287
Richard J. Buchholz
Chief Financial Officer
$477,989 $1,899,947 $2,707,684
Bryan K. Phillips
SVP, General Counsel, CCO and Corporate Secretary
$475,182 $1,899,947 $2,702,484

CEO Pay Ratio

16:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,711,784
Avg Employee Cost (SGA/emp): $468,595
Employees: 1,333

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,333
+7.0% YoY
Revenue / Employee
$684,157
Rev: $911,981,000
Profit / Employee
$109,094
NI: $145,422,000
SGA / Employee
$468,595
Avg labor cost proxy
R&D / Employee
$77,393
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -21.0% -18.3% -19.0% -19.7% -14.6% -12.4% -12.0% -10.9% -6.5% -4.0% -2.9% 1.0% 5.3% 8.5% 10.9% 8.1% 6.5% 19.8% 18.4% 18.0% 17.96%
ROA -17.1% -14.6% -15.1% -15.6% -12.5% -10.4% -10.1% -9.0% -5.6% -3.4% -2.5% 0.9% 4.6% 7.2% 9.4% 6.9% 5.6% 17.0% 16.0% 15.6% 15.63%
ROIC -86.6% -64.7% -56.7% -53.1% -74.9% -70.3% -65.9% -49.4% -37.5% -23.2% -16.5% -4.5% 3.9% 12.0% 15.3% 9.1% 8.4% 22.3% 19.6% 19.7% 19.73%
ROCE -18.3% -15.7% -16.3% -17.0% -10.0% -8.5% -9.0% -8.8% -8.1% -5.7% -4.9% -0.4% 4.3% 9.8% 12.6% 10.0% 9.2% 7.4% 7.8% 7.7% 7.71%
Gross Margin 86.0% 85.8% 85.6% 84.5% 81.9% 83.9% 84.4% 83.9% 84.1% 85.4% 84.9% 84.8% 84.1% 85.0% 84.7% 84.0% 85.8% 86.6% 86.5% 85.5% 85.48%
Operating Margin -15.9% -2.3% -23.1% -15.3% -15.7% -0.2% -15.2% -11.0% -8.8% 4.8% -9.3% 2.6% 7.0% 13.3% -0.7% -1.5% 4.3% 17.1% -0.5% -0.3% -0.26%
Net Margin -16.8% -3.0% -24.1% -15.9% -15.4% 2.3% -12.1% -7.9% -5.6% 7.7% -6.1% 5.0% 9.1% 14.7% 1.5% -1.7% 4.4% 50.6% -5.5% 0.2% 0.16%
EBITDA Margin -15.4% -1.9% -22.6% -14.7% -14.1% 2.8% -14.8% -10.5% -8.3% 8.3% -8.8% 6.2% 10.9% 23.7% 0.8% 0.5% 7.7% 20.2% 3.7% 2.0% 2.04%
FCF Margin -14.8% -10.6% -10.3% -7.5% -3.9% 0.6% 2.4% 3.6% 1.4% 0.2% 0.5% -1.3% 5.1% 11.4% 9.4% 9.9% 11.2% 8.6% 10.6% 13.0% 13.03%
OCF Margin -12.4% -8.6% -8.6% -6.1% -2.0% 2.8% 4.9% 6.5% 4.7% 3.9% 5.3% 4.2% 10.4% 16.2% 13.7% 13.6% 15.1% 12.8% 14.9% 17.5% 17.48%
ROE 3Y Avg snapshot only 8.38%
ROE 5Y Avg snapshot only -0.39%
ROA 3Y Avg snapshot only 7.34%
ROIC 3Y Avg snapshot only 16.53%
ROIC Economic snapshot only 12.59%
Cash ROA snapshot only 16.96%
Cash ROIC snapshot only 29.41%
CROIC snapshot only 21.93%
NOPAT Margin snapshot only 11.72%
Pretax Margin snapshot only 7.72%
R&D / Revenue snapshot only 11.09%
SGA / Revenue snapshot only 69.02%
SBC / Revenue snapshot only 13.29%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -134.88 -149.80 -166.12 -114.77 -99.29 -169.54 -156.13 -231.03 -177.85 -290.79 -404.29 677.02 195.63 106.54 72.60 72.08 49.29 18.53 11.29 9.56 15.012
P/S Ratio 31.63 26.98 26.92 16.75 14.37 18.66 14.60 18.04 10.22 9.84 9.62 5.77 8.56 7.10 5.75 4.45 2.49 2.95 1.62 1.44 2.251
P/B Ratio 28.86 27.50 31.39 22.21 10.65 15.34 13.49 17.93 10.71 10.74 10.80 6.38 9.28 8.27 7.59 5.65 3.30 3.45 1.87 1.56 2.444
P/FCF -214.05 -254.07 -261.34 -222.81 -366.91 3076.90 600.50 500.78 718.63 6006.91 1936.39 -431.88 169.23 62.56 61.23 45.04 22.23 34.34 15.31 11.03 11.026
P/OCF — — — — — 657.72 296.40 278.94 218.62 249.51 182.49 137.08 82.54 43.77 42.10 32.60 16.43 23.04 10.84 8.22 8.219
EV/EBITDA -141.05 -158.38 -177.25 -121.58 -99.60 -175.94 -144.90 -194.81 -123.32 -181.55 -220.51 3012.70 168.49 68.86 48.45 43.66 24.87 32.62 15.31 12.03 12.028
EV/Revenue 30.74 26.21 26.27 16.21 13.17 17.57 13.65 17.19 9.45 9.15 8.99 5.18 8.05 6.59 5.35 4.13 2.16 2.65 1.34 1.11 1.112
EV/EBIT -137.51 -153.54 -171.34 -117.32 -96.19 -168.27 -138.32 -185.48 -116.40 -166.50 -197.82 -1403.92 194.90 75.28 53.50 50.31 29.77 40.18 19.14 15.17 15.170
EV/FCF -208.02 -246.80 -255.08 -215.51 -336.25 2897.95 561.39 477.36 664.49 5581.59 1809.49 -387.82 159.14 58.02 56.97 41.89 19.29 30.82 12.68 8.54 8.536
Earnings Yield -0.7% -0.7% -0.6% -0.9% -1.0% -0.6% -0.6% -0.4% -0.6% -0.3% -0.2% 0.1% 0.5% 0.9% 1.4% 1.4% 2.0% 5.4% 8.9% 10.5% 10.46%
FCF Yield -0.5% -0.4% -0.4% -0.4% -0.3% 0.0% 0.2% 0.2% 0.1% 0.0% 0.1% -0.2% 0.6% 1.6% 1.6% 2.2% 4.5% 2.9% 6.5% 9.1% 9.07%
PEG Ratio snapshot only 0.093
Price/Tangible Book snapshot only 1.564
EV/OCF snapshot only 6.363
EV/Gross Profit snapshot only 1.291
Acquirers Multiple snapshot only 18.466
Shareholder Yield snapshot only 7.75%
Graham Number snapshot only $54.73
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.61 6.50 6.08 5.62 10.05 8.66 8.91 8.40 8.14 7.60 7.93 9.25 7.84 7.13 9.01 6.14 5.29 6.08 6.34 8.55 8.551
Quick Ratio 7.14 6.08 5.57 5.15 9.75 8.47 8.65 8.09 7.76 7.17 7.25 8.35 6.94 6.22 7.44 4.84 4.01 4.56 4.48 6.16 6.156
Debt/Equity 0.14 0.15 0.15 0.14 0.02 0.02 0.02 0.04 0.05 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.035
Net Debt/Equity -0.81 -0.79 -0.75 -0.73 -0.89 -0.89 -0.88 -0.84 -0.81 -0.76 -0.71 -0.65 -0.55 -0.60 -0.53 -0.40 -0.44 -0.35 -0.32 -0.35 -0.353
Debt/Assets 0.11 0.12 0.12 0.11 0.02 0.02 0.01 0.04 0.04 0.04 0.04 0.03 0.03 0.04 0.05 0.04 0.04 0.04 0.03 0.03 0.031
Debt/EBITDA -0.71 -0.88 -0.88 -0.78 -0.20 -0.22 -0.19 -0.50 -0.58 -0.79 -0.91 20.21 0.70 0.41 0.36 0.41 0.43 0.43 0.37 0.35 0.350
Net Debt/EBITDA 4.09 4.67 4.35 4.11 9.08 10.86 10.10 9.56 10.05 13.83 15.46 -342.25 -10.69 -5.39 -3.62 -3.28 -3.78 -3.72 -3.17 -3.51 -3.509
Interest Coverage -21.16 -18.72 -18.87 -19.83 -21.53 -25.40 -40.02 -74.34 — — — — — 3192.27 3816.50 2722.65 1730.41 439.34 467.68 495.38 495.383
Equity Multiplier 1.27 1.29 1.29 1.29 1.12 1.14 1.13 1.17 1.18 1.18 1.16 1.14 1.14 1.17 1.15 1.18 1.21 1.16 1.15 1.12 1.122
Cash Ratio snapshot only 4.505
Debt Service Coverage snapshot only 624.752
Cash to Debt snapshot only 11.023
FCF to Debt snapshot only 4.025
Defensive Interval snapshot only 215.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.73 0.81 0.93 1.07 0.86 0.95 1.08 1.16 0.98 1.01 1.05 1.05 1.05 1.08 1.19 1.13 1.10 1.06 1.11 1.04 1.040
Inventory Turnover 2.39 2.59 2.22 2.50 3.59 4.54 4.01 4.03 4.40 4.22 3.14 2.68 2.46 2.16 1.73 1.48 1.27 1.18 0.98 0.85 0.853
Receivables Turnover 8.41 7.88 9.34 9.22 9.27 8.55 9.89 10.13 9.51 8.27 10.01 9.86 9.37 8.78 10.19 7.92 8.93 8.57 9.26 7.46 7.458
Payables Turnover 3.50 3.53 2.86 3.56 3.64 3.43 2.84 3.07 3.01 2.94 2.53 2.91 3.07 3.17 3.54 3.08 2.83 3.54 3.67 3.11 3.106
DSO 43 46 39 40 39 43 37 36 38 44 36 37 39 42 36 46 41 43 39 49 48.9 days
DIO 153 141 164 146 102 80 91 91 83 86 116 136 148 169 210 246 287 309 373 428 427.7 days
DPO 104 104 128 103 100 106 128 119 121 124 144 125 119 115 103 118 129 103 100 118 117.5 days
Cash Conversion Cycle 92 84 76 83 41 17 -1 8 0 7 8 48 68 96 143 174 199 248 313 359 359.1 days
Fixed Asset Turnover snapshot only 7.081
Operating Cycle snapshot only 476.6 days
Cash Velocity snapshot only 2.803
Capital Intensity snapshot only 1.030
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 1.1% 1.0% 95.3% 71.8% 73.3% 74.7% 77.7% 74.9% 63.7% 53.2% 41.7% 34.1% 32.5% 28.5% 27.1% 22.0% 16.8% 13.6% 8.9% 4.3% 4.35%
Net Income 19.8% 26.5% 25.6% 6.9% -7.0% -6.8% -2.6% 6.5% 35.0% 52.9% 63.9% 1.1% 2.0% 3.5% 5.2% 7.8% 34.8% 1.7% 97.2% 1.5% 1.54%
EPS 21.2% 27.6% 26.6% 8.1% -3.5% 3.3% 3.0% 11.7% 37.5% 52.9% 64.6% 1.1% 2.0% 3.5% 5.1% 8.1% 39.5% 1.9% 1.1% 1.6% 1.59%
FCF 48.2% 55.3% 48.2% 41.0% 54.1% 1.1% 1.4% 1.8% 1.6% -58.6% -71.0% -1.5% 3.7% 88.0% 23.0% 10.0% 1.6% -13.9% 22.7% 37.7% 37.74%
EBITDA 21.5% 28.6% 28.0% 8.6% -5.2% -5.5% -12.9% -15.8% 5.1% 22.7% 38.6% 1.0% 1.8% 3.4% 4.4% 66.3% 1.1% -3.4% -13.6% 1.9% 1.86%
Op. Income 22.8% 29.1% 27.5% 7.8% -8.8% -19.4% -26.9% -28.7% -1.7% 15.4% 29.5% 73.3% 1.3% 1.9% 2.4% 3.9% 1.7% 41.2% 3.0% 30.7% 30.73%
OCF Growth snapshot only 33.74%
Asset Growth snapshot only 15.43%
Equity Growth snapshot only 21.80%
Debt Growth snapshot only -12.00%
Shares Change snapshot only -1.92%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.0% 79.2% 66.6% 67.6% 69.4% 70.7% 74.9% 86.3% 80.9% 75.6% 70.1% 59.1% 55.5% 51.0% 47.4% 42.0% 36.3% 30.8% 25.2% 19.5% 19.54%
Revenue 5Y — — — — — — — 1.2% 88.4% 72.8% 63.4% 61.7% 60.2% 57.8% 57.3% 60.3% 55.8% 51.2% 46.8% 38.7% 38.69%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 1.1% 82.7% 69.6% 70.0% 70.6% 70.9% 74.8% 86.0% 80.5% 75.5% 69.9% 58.9% 55.1% 50.3% 46.7% 41.5% 36.7% 31.6% 26.2% 20.7% 20.72%
Gross Profit 5Y — — — — — — — 1.2% 89.9% 74.3% 64.7% 62.8% 61.1% 58.3% 57.6% 60.5% 55.8% 51.4% 47.1% 39.0% 38.98%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — 2.2% 1.0% 83.5% 83.50%
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — 1.2% 81.1% 66.5% 66.52%
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 28.7% 13.8% 15.2% 16.3% 42.3% 46.1% 51.1% 31.6% 33.0% 34.0% 35.9% 38.8% 41.9% 39.9% 36.1% 40.1% 15.3% 17.1% 16.8% 14.4% 14.41%
Assets 5Y — — — — — — — 35.8% 37.4% 27.6% 29.3% 31.5% 34.2% 34.9% 34.5% 24.2% 24.3% 26.4% 27.2% 27.7% 27.74%
Equity 3Y 30.9% 11.8% 12.7% 14.2% 47.7% 52.5% 58.2% 31.3% 33.5% 35.6% 38.2% 42.6% 46.8% 44.4% 41.4% 44.0% 12.3% 16.3% 16.2% 16.0% 15.97%
Book Value 3Y 20.6% 3.7% 6.8% 8.6% 39.8% 41.4% 48.7% 26.8% 29.5% 30.5% 34.2% 37.5% 41.2% 38.9% 36.9% 40.8% 10.6% 17.6% 16.8% 16.4% 16.35%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.92 0.91 0.89 0.91 0.92 0.92 0.93 0.87 0.88 0.89 0.89 0.92 0.94 0.95 0.97 0.98 0.99 0.99 0.99 0.97 0.972
Earnings Stability 0.73 0.59 0.47 0.59 0.64 0.48 0.30 0.43 0.25 0.03 0.03 0.24 0.38 0.52 0.60 0.79 0.83 0.80 0.84 0.85 0.848
Margin Stability 0.98 0.97 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.99 0.99 0.99 0.99 1.00 0.99 0.99 0.99 0.989
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 1 1 0 1 1 1 0 1 1 1 1 0
Earnings Persistence 0.92 0.89 0.90 0.97 0.97 0.97 0.99 0.97 0.86 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — 0.00 0.70 0.08 0.35 0.13 0.129
ROE Trend 0.01 0.06 0.10 0.04 0.13 0.13 0.14 0.13 0.10 0.10 0.11 0.14 0.13 0.14 0.16 0.11 0.07 0.17 0.13 0.12 0.120
Gross Margin Trend 0.02 0.02 0.01 0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.00 -0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.015
FCF Margin Trend 0.37 0.35 0.32 0.35 0.33 0.30 0.27 0.18 0.11 0.05 0.04 0.01 0.06 0.11 0.08 0.09 0.08 0.03 0.06 0.09 0.088
Sustainable Growth Rate — — — — — — — — — — — 1.0% 5.3% 8.5% 10.9% 8.1% 6.5% 19.8% 18.4% 18.0% 17.96%
Internal Growth Rate — — — — — — — — — — — 0.9% 4.8% 7.8% 10.4% 7.5% 5.9% 20.4% 19.0% 18.5% 18.52%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.53 0.48 0.53 0.42 0.14 -0.26 -0.53 -0.83 -0.81 -1.17 -2.22 4.94 2.37 2.43 1.72 2.21 3.00 0.80 1.04 1.16 1.163
FCF/OCF 1.19 1.23 1.20 1.24 1.96 0.21 0.49 0.56 0.30 0.04 0.09 -0.32 0.49 0.70 0.69 0.72 0.74 0.67 0.71 0.75 0.745
FCF/Net Income snapshot only 0.867
OCF/EBITDA snapshot only 1.890
CapEx/Revenue 2.4% 2.0% 1.7% 1.4% 1.9% 2.2% 2.5% 2.9% 3.3% 3.8% 4.8% 5.5% 5.3% 4.9% 4.3% 3.8% 4.0% 4.2% 4.4% 4.4% 4.45%
CapEx/Depreciation snapshot only 2.324
Accruals Ratio -0.08 -0.08 -0.07 -0.09 -0.11 -0.13 -0.15 -0.16 -0.10 -0.07 -0.08 -0.04 -0.06 -0.10 -0.07 -0.08 -0.11 0.03 -0.01 -0.03 -0.025
Sloan Accruals snapshot only 0.047
Cash Flow Adequacy snapshot only 3.929
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — 86.9% 27.4% 1.5% 2.6% 3.2% 4.8% 1.3% 76.3% 74.1% 74.06%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 1.4% 3.6% 4.4% 9.8% 7.2% 6.8% 7.7% 7.75%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 1.4% 3.6% 4.3% 9.5% 6.9% 6.2% 7.3% 7.32%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 1.4% 3.6% 4.3% 9.5% 6.9% 6.2% 7.3% 7.32%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.01 1.01 1.01 1.02 1.02 1.03 1.06 1.12 0.70 0.89 0.92 0.92 0.90 0.86 2.21 2.05 1.95 1.946
Interest Burden (EBT/EBIT) 1.05 1.05 1.05 1.05 1.05 1.04 0.93 0.83 0.69 0.58 0.47 -3.28 1.19 0.83 0.86 0.83 0.81 1.09 1.00 1.05 1.053
EBIT Margin -0.22 -0.17 -0.15 -0.14 -0.14 -0.10 -0.10 -0.09 -0.08 -0.05 -0.05 -0.00 0.04 0.09 0.10 0.08 0.07 0.07 0.07 0.07 0.073
Asset Turnover 0.73 0.81 0.93 1.07 0.86 0.95 1.08 1.16 0.98 1.01 1.05 1.05 1.05 1.08 1.19 1.13 1.10 1.06 1.11 1.04 1.040
Equity Multiplier 1.23 1.26 1.26 1.26 1.17 1.19 1.18 1.20 1.15 1.16 1.15 1.15 1.16 1.18 1.16 1.16 1.18 1.17 1.15 1.15 1.150
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.73 $-1.54 $-1.55 $-1.59 $-1.79 $-1.49 $-1.50 $-1.41 $-1.12 $-0.70 $-0.53 $0.20 $1.08 $1.74 $2.19 $1.80 $1.51 $4.98 $4.57 $4.67 $4.67
Book Value/Share $8.07 $8.37 $8.18 $8.23 $16.66 $16.42 $17.35 $18.11 $18.53 $18.93 $19.89 $20.98 $22.74 $22.43 $20.97 $22.97 $22.52 $26.74 $27.61 $28.53 $28.63
Tangible Book/Share $8.07 $8.37 $8.18 $8.23 $16.66 $16.42 $17.35 $18.11 $18.53 $18.93 $19.89 $20.98 $22.74 $22.43 $20.97 $22.97 $22.52 $26.74 $27.61 $28.53 $28.53
Revenue/Share $7.36 $8.53 $9.54 $10.90 $12.34 $13.50 $16.03 $18.00 $19.42 $20.66 $22.32 $23.21 $24.67 $26.11 $27.72 $29.19 $29.82 $31.21 $31.89 $31.05 $31.17
FCF/Share $-1.09 $-0.91 $-0.98 $-0.82 $-0.48 $0.08 $0.39 $0.65 $0.28 $0.03 $0.11 $-0.31 $1.25 $2.96 $2.60 $2.88 $3.34 $2.69 $3.37 $4.05 $4.06
OCF/Share $-0.91 $-0.73 $-0.82 $-0.66 $-0.25 $0.38 $0.79 $1.16 $0.91 $0.82 $1.18 $0.98 $2.56 $4.24 $3.78 $3.98 $4.52 $4.00 $4.76 $5.43 $5.45
Cash/Share $7.70 $7.83 $7.39 $7.11 $15.15 $14.94 $15.54 $15.98 $15.81 $15.23 $14.90 $14.46 $13.42 $14.49 $12.18 $10.20 $10.90 $10.55 $9.89 $11.08 $11.12
EBITDA/Share $-1.60 $-1.41 $-1.41 $-1.45 $-1.63 $-1.35 $-1.51 $-1.59 $-1.49 $-1.04 $-0.91 $0.04 $1.18 $2.50 $3.06 $2.76 $2.59 $2.54 $2.79 $2.87 $2.87
Debt/Share $1.14 $1.25 $1.25 $1.14 $0.32 $0.29 $0.29 $0.80 $0.86 $0.82 $0.83 $0.81 $0.83 $1.03 $1.11 $1.12 $1.10 $1.10 $1.03 $1.01 $1.01
Net Debt/Share $-6.56 $-6.59 $-6.14 $-5.98 $-14.82 $-14.65 $-15.25 $-15.18 $-14.95 $-14.40 $-14.08 $-13.65 $-12.59 $-13.45 $-11.07 $-9.08 $-9.80 $-9.45 $-8.86 $-10.08 $-10.08
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 9.378
Altman Z-Prime snapshot only 17.232
Piotroski F-Score 4 4 4 4 5 6 6 6 5 5 5 8 6 5 6 6 7 7 7 8 8
Beneish M-Score 7.69 16.38 16.56 -2.27 -2.14 -2.25 -2.33 -2.51 -2.41 -2.10 -1.74 -1.63 -0.05 -1.83 -2.37 -1.46 -2.91 -1.59 -1.49 -2.64 -2.642
Ohlson O-Score snapshot only -13.326
ROIC (Greenblatt) snapshot only 9.92%
Net-Net WC snapshot only $17.56
EVA snapshot only $51943469.63
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 59.52 61.07 62.18 63.66 64.24 73.54 71.23 72.18 82.26 79.43 80.68 69.97 93.28 96.18 96.58 96.37 95.98 95.89 95.90 95.95 95.952
Credit Grade snapshot only 1
Credit Trend snapshot only -0.420
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 91
Sector Credit Rank snapshot only 93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms